2021
DOI: 10.1097/ico.0000000000002738
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Fuchs Endothelial Corneal Dystrophy in Clinical Practice and Clinical Trials

Abstract: Corneal tomography has an emerging role in the assessment of Fuchs endothelial corneal dystrophy (FECD) in clinical practice and potentially for future clinical trials. Posterior elevation and pachymetry maps derived from elevation based Scheimpflug tomography can detect early corneal edema, even at a subclinical stage, enabling clinicians to better counsel patients about their vision and the risk of disease progression with and without cataract surgery. Tomographic imaging provides a functional assessment of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 14 publications
0
7
0
Order By: Relevance
“… 52 Scheimpflug tomography can generate useful pachymetry and posterior elevation maps, providing functional assessments of the health of the corneal endothelium in FECD. 53 However, because these Scheimpflug imaging parameters related to the thickness of the cornea are disturbed only in late FECD after significant loss of the endothelium and the onset of edema, they may not be ideal as end points to test the efficacy of molecular therapies intended to slow progression in patients with mild or moderate disease.…”
Section: Discussionmentioning
confidence: 99%
“… 52 Scheimpflug tomography can generate useful pachymetry and posterior elevation maps, providing functional assessments of the health of the corneal endothelium in FECD. 53 However, because these Scheimpflug imaging parameters related to the thickness of the cornea are disturbed only in late FECD after significant loss of the endothelium and the onset of edema, they may not be ideal as end points to test the efficacy of molecular therapies intended to slow progression in patients with mild or moderate disease.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, when classifying eyes based on the presence of subclinical edema independently from the Krachmer grading, 10,19 eyes without preoperative edema reached comparable BCVA outcomes as the control group while eyes with preoperative subclinical edema had worse BCVA outcomes than the control group. For eyes without preoperative edema, the anterior corneal backscatter was comparable to the control group in the 2-to 6-mm zone and only a borderline difference in the 0to 2-mm zone (Table 4).…”
Section: Discussionmentioning
confidence: 93%
“…Sun et al in 2019 proposed a revised classification of subclinical edema in FECD based on topographic images and the presence of (1) loss of regular isopachs, (2) displacement of the thinnest point, and (3) focal posterior surface depression, all independent of CCT. [5][6][7][8] Figure 3, A and B and Table 1 present the comparative topography of the left eye after PRK in 2007 and during the acute presentation of FECD in 2018, respectively. Over the span of 8 years between 2010 when corneal guttae was first noted and the acute presentation in 2018, mild changes were observed in astigmatism and manifest refraction of the patient along with topographic signs suggestive of subclinical edema associated with FECD and a progressively thickening CCT in the left eye.…”
Section: Discussionmentioning
confidence: 99%